Argenx SE (NASDAQ:ARGX) stock is trading lower on Monday after the U.S. Food and Drug Administration (FDA) signaled serious risks/safety identified by the reporting system for Vyvgart Hytrulo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback